Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus

Journal of Virology

Volumn 75, Issue 18, 2001, Pages 8733-8741

  Wills, K N ^a   Atencio, I A ^a   Avanzini, J B ^a   Neuteboom, S ^a   Phelan, A ^a   Philopena, J ^a   Sutjipto, S ^a   Vaillancourt, M T ^a   Shu Fen Wen, ^a   Ralston, R O ^a   Johnson, D E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; HYBRID PROTEIN; PROTEIN P53; PROTEIN VP22; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; GENE THERAPY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; VIRUS RECOMBINANT;

ADENOVIRUSES, HUMAN; ANIMALS; APOPTOSIS; CASPASE 9; CASPASES; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; HUMANS; NEOPLASMS, EXPERIMENTAL; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VIRAL STRUCTURAL PROTEINS;

EID: 0034887103     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.18.8733-8741.2001     Document Type: Article

References (31)

1. Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment
2. Evaluation of VP22 spread in tissue culture
3. Guidance for human somatic cell therapy and gene therapy
4. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
5. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer
6. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22
7. Regulation of p53 downstream genes
8. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
9. The herpes simplex virus type 1 tegument protein VP22 is encoded by the gene UL49
10. Intercellular trafficking and protein delivery by a herpesvirus structural protein
11. Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells
12. MDM2 gene amplification and transcript levels in human sarcomas: Relationship to TP53 gene status
13. P53 gene mutation and ink-4a-arf deletion appear to be two mutually exclusive events in human glioblastoma
14. A novel method for real-time quantitative RT-PCR
15. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein
16. Mdm2 promotes the rapid degradation of p53
17. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase
18. Purification of type-5 recombinant adenovirus encoding human p53 by column chromatography
19. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo
20. P53 and p21 (Waf1/Cip1) mRNA expression associated with DNA damage and repair in acute immune complex alveolitis in mice
21. The role of the p53 protein in the apoptotic response
22. P53 tumor suppressor gene therapy for cancer
23. Sensitivity and reproducibility in adenoviral infections titer determination
24. Intercellular delivery of functional p53 by the herpesvirus protein VP22
25. The p53 pathway
26. Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles
27. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition
28. Gene therapy for hepatocellular carcinoma: Chemosensitivity conferred by adenovirus mediated transfer of the HSV-1 thymidine kinase gene
29. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer
30. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus